VERIPAD, Inc.

We are a disruptive biotech startup that is leveraging mobile technology to reduce moralities from counterfeit medication. In certain regions, up to 20-50% of medications are counterfeit. Counterfeit medications may not only lead to serious health hazards but also greater socioeconomic impacts for patients. Our team is working to bring affordable and accurate technological solutions to low- and middle- income countries. We have designed a novel software that incorporates machine learning and computer vision to analyze the results of comprehensive test cards to truly democratize drug authentication.